LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 27.84 | 770.25 | 1392 | 2833 | 0.4912 | 0.3701 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 27.84 | 770.25 | 1179 | 2833 | 0.4160 | 0.2542 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 27.84 | 770.25 | 1447 | 2833 | 0.5106 | 0.3986 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 30.06 | 770.25 | 1495 | 3106 | 0.4813 | 0.3905 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 30.06 | 770.25 | 1270 | 3106 | 0.4089 | 0.2822 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 30.06 | 770.25 | 1432 | 3106 | 0.4610 | 0.3610 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 32.28 | 770.25 | 1482 | 3392 | 0.4368 | 0.3579 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 32.28 | 770.25 | 1340 | 3392 | 0.3950 | 0.2954 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 32.28 | 770.25 | 1557 | 3392 | 0.4589 | 0.3896 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 34.50 | 770.25 | 1589 | 3712 | 0.4281 | 0.3760 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 34.50 | 770.25 | 1387 | 3712 | 0.3737 | 0.2960 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 34.50 | 770.25 | 1668 | 3712 | 0.4494 | 0.4057 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.73 | 770.25 | 1715 | 4086 | 0.4197 | 0.3945 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.73 | 770.25 | 1634 | 4086 | 0.3999 | 0.3667 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.73 | 770.25 | 1693 | 4086 | 0.4143 | 0.3870 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 38.95 | 770.25 | 1735 | 4543 | 0.3818 | 0.3732 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 38.95 | 770.25 | 1696 | 4543 | 0.3733 | 0.3611 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 38.95 | 770.25 | 1878 | 4543 | 0.4133 | 0.4163 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.17 | 770.25 | 1880 | 5010 | 0.3752 | 0.3914 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.17 | 770.25 | 1899 | 5010 | 0.3790 | 0.3966 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.17 | 770.25 | 2085 | 5010 | 0.4161 | 0.4457 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 43.39 | 770.25 | 1977 | 5404 | 0.3658 | 0.3985 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 43.39 | 770.25 | 2033 | 5404 | 0.3762 | 0.4124 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 43.39 | 770.25 | 2141 | 5404 | 0.3962 | 0.4387 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.61 | 770.25 | 2237 | 5813 | 0.3848 | 0.4414 | MN20160304_L02 | C10 |